BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3680397)

  • 1. Altered hormonal responses: markers for embryonal and embryonic carcinoma stem cells and their differentiated derivatives.
    Liapi C; Gerbaud P; Anderson WB; Brion DE
    J Cell Physiol; 1987 Nov; 133(2):405-8. PubMed ID: 3680397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered activation by calcitonin and inhibition by somatostatin of human embryonal carcinoma cell adenylate cyclase with retinoic acid-induced differentiation.
    Liapi C; Anderson WB; Evain-Brion D
    Dev Biol; 1986 Jan; 113(1):141-6. PubMed ID: 2867942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of immunoreactive calcitonin and parathyroid hormone by embryonal carcinoma cells: alteration with retinoic acid-induced differentiation.
    Evain-Brion D; Binet E; Donnadieu M; Laurent P; Anderson WB
    Dev Biol; 1984 Aug; 104(2):406-12. PubMed ID: 6745491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin-responsive adenylate cyclase in cultured F9 embryonal carcinoma cells.
    Binet E; Evain D; Anderson WB
    Exp Cell Res; 1980 Oct; 129(2):466-9. PubMed ID: 6253308
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of parathyroid hormone- and calcitonin-activated adenylate cyclases in embryonic chicken limb and in cultured cells from embryonic chicken limb.
    Zull JE; Krug S; Abel D; Caplan AI
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3871-5. PubMed ID: 279002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.
    Chan SD; Strewler GJ; King KL; Nissenson RA
    Mol Endocrinol; 1990 Apr; 4(4):638-46. PubMed ID: 2177844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in calcitonin and parathyroid hormone responsiveness of adenylate cyclase in F9 embryonal carcinoma cells treated with retinoic acid and dibutyryl cyclic AMP.
    Evain D; Binet E; Anderson WB
    J Cell Physiol; 1981 Dec; 109(3):453-9. PubMed ID: 6274880
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in the activity and subcellular distribution of cyclic-AMP-dependent protein kinases with retinoic-acid-induced differentiation of embryonal carcinoma cells.
    Plet A; Gerbaud P; Anderson WB; Brion DE
    Differentiation; 1985; 30(2):159-64. PubMed ID: 3007248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth.
    Nagarajan L; Anderson WB; Nissley SP; Rechler MM; Jetten AM
    J Cell Physiol; 1985 Aug; 124(2):199-206. PubMed ID: 4044654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin and calcitonin gene-related peptide are chemotactic for F9 embryonal carcinoma cells.
    Gerbaud P; Segond N; Moukhtar MM; Evain-Brion D
    Endocrinology; 1991 Nov; 129(5):2530-4. PubMed ID: 1935783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of parathyroid hormone and calcitonin on adenylate cyclase in murine mononuclear phagocytes.
    Minkin C; Blackman L; Newbrey J; Pokress S; Posek R; Walling M
    Biochem Biophys Res Commun; 1977 Jun; 76(3):875-81. PubMed ID: 901438
    [No Abstract]   [Full Text] [Related]  

  • 12. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo.
    Lehtonen E; Laasonen A; Tienari J
    Int J Dev Biol; 1989 Mar; 33(1):105-15. PubMed ID: 2485690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histochemical localization of hormone sensitive adenylate cyclase in defined nephron epithelia in culture.
    Wilson PD; Horster MF
    Histochemistry; 1985; 82(6):539-45. PubMed ID: 4030408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic effects of 25(OH)vitamin D3 and peptide hormones on the activation of adenylate cyclase/cyclic AMP system in renal tissue in vitro.
    Wald H; Popovtzer MM
    Adv Exp Med Biol; 1980; 128():625-33. PubMed ID: 6252764
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of F9 embryonal carcinoma cell differentiation by inhibition of polyamine synthesis.
    Oredsson SM; Billgren M; Heby O
    Eur J Cell Biol; 1985 Sep; 38(2):335-43. PubMed ID: 3930245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exemption of satellite DNA from demethylation in immortalized differentiated derivatives of F9 mouse embryonal carcinoma cells.
    Teubner B; Schulz WA
    Exp Cell Res; 1994 Feb; 210(2):192-200. PubMed ID: 7507850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fucosyltransferase in teratocarcinoma stem cells. Decreased activity accompanying differentiation to parietal endoderm cells.
    Muramatsu H; Muramatsu T
    FEBS Lett; 1983 Nov; 163(2):181-4. PubMed ID: 6315485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activation of adenylate cyclase by parathyroid hormone and calcitonin during normal and hydrocortisone-induced cleft palate development in the golden hamster.
    Waterman RE; Palmer GC; Palmer SJ; Palmer SM
    Anat Rec; 1977 Aug; 188(4):431-43. PubMed ID: 197859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of alpha 6/beta 1 integrin expression during differentiation of F9 murine embryonal carcinoma cells to parietal endoderm.
    Morini M; Piccini D; Barbieri O; Astigiano S
    Exp Cell Res; 1997 May; 232(2):304-12. PubMed ID: 9168806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in the c-myb gene transcript during differentiation of mouse teratocarcinoma stem cells.
    Fukuda M; Ikuma S; Setoyama C; Shimada K
    Biochem Int; 1987 Jul; 15(1):73-9. PubMed ID: 2840075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.